Browsing publications by Dr Petros Perros

Newcastle AuthorsTitleYearFull text
Dr Petros Perros
Treatment Satisfaction, Symptom Control, and Quality of Life (QoL) With Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumor (NET) Patients With Carcinoid Syndrome (CS): Results From the SymNET Study2015
Dr Petros Perros
Evaluation of the Clinical Utility of Plasma Biomarkers in Diagnosis of Neuroendocrine Tumors2014
Costanzo Di Maria
Dr John Allen
Christopher Neoh
Dr Petros Perros
Novel Thermal Imaging Analysis Technique for Detecting Inflammation in Thyroid Eye Disease2014
Professor Simon Pearce
Dr Stephen Ball
Dr Richard Quinton
Dr Petros Perros
Patient Knowledge of Antithyroid Drug-Induced Agranulocytosis2014
Dr Sarah Johnson
Dr Steven Hardy
Dr David Bourn
Dr Ujjal Mallick
Dr Petros Perros
et al.
Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology2014
Dr Earn Gan
Katie MacArthur
Dr Anna Mitchell
Dr Petros Perros
Dr Stephen Ball
et al.
Residual Adrenal Function in Autoimmune Addison's Disease: Improvement After Tetracosactide (ACTH1-24) Treatment2014
Dr Anna Mitchell
Dr Catherine Napier
Dr Naveen Siddaramaiah
Dr Petros Perros
Dr Andy James
et al.
Saving lives of in-patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle-upon-Tyne Hospitals e-Prescribing platform2014
Dr Petros Perros
SYMNET: A Study of Patient-Reported Outcomes (PROs) Associated with Lanreotide Autogel (LAN) for the Control of Carcinoid Syndrome (CS) Symptoms in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients (Pts)2014
Dr Anna Mitchell
Dr Earn Gan
Christopher Neoh
Dr Alison Dickinson
Dr Petros Perros
et al.
The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy2013
Dr Petros Perros
Management plan and delivery of care in Graves' ophthalmopathy patients2012
12345678